USP9X PROMOTES LPS-INDUCED FIBROBLAST CELL APOPTOSIS, INFLAMMATION, AND OXIDATIVE STRESS BY REGULATION OF TBL1XR1 DEUBIQUITINATION.

IF 2.9 3区 医学 Q2 CRITICAL CARE MEDICINE SHOCK Pub Date : 2025-02-01 DOI:10.1097/SHK.0000000000002442
Juan Yang, Yingying Yao, Shuo Fan, Xiaoyan Li
{"title":"USP9X PROMOTES LPS-INDUCED FIBROBLAST CELL APOPTOSIS, INFLAMMATION, AND OXIDATIVE STRESS BY REGULATION OF TBL1XR1 DEUBIQUITINATION.","authors":"Juan Yang, Yingying Yao, Shuo Fan, Xiaoyan Li","doi":"10.1097/SHK.0000000000002442","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Background: Ubiquitination and deubiquitination are involved in the progression of human diseases, including acute pneumonia. In this study, we aimed to explore the functions of ubiquitin-specific peptidase 9X-linked (USP9X) in lipopolysaccharide (LPS)-treated WI-38 cells. Methods: WI-38 cells were treated with LPS to induce the cellular damage and inflammation. 3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) assay, and 5-ethynyl-2'-deoxyuridine (EdU) assay were performed to examine the proliferation of LPS-treated WI-38 cells. Flow cytometry analysis was conducted to detect LPS-treated WI-38 cell apoptosis. ELISA kits were utilized to determine the concentrations of inflammatory factors (IL-1β and TNF-α). Superoxide dismutase activity and reactive oxygen species level were examined with related kits. Ubibrowser (http://ubibrowser.bio-it.cn/ubibrowser/), ubiquitination assay, and co-immunoprecipitation assay demonstrated the interaction between USP9X and transducin β-like 1X related protein 1 (TBL1XR1). qRT-PCR assay and western blot assay were manipulated to determine the expression of USP9X and TBL1XR1. TBL1XR1 and USP9X knockdown experiments were conducted to explore their functions on LPS-induced WI-38 cell injury and inflammation. Results: TBL1XR1 expression was upregulated in LPS-treated WI-38 cells. TBL1XR1 knockdown promoted cell proliferation and repressed apoptosis, inflammation, and oxidative stress in LPS-treated WI-38 cells. Moreover, USP9X deubiquitinated TBL1XR1 to regulate TBL1XR1 expression. USP9X knockdown restored the effects of LPS on WI-38 cell proliferation, apoptosis, inflammation, and oxidative stress, but these effects of USP9X knockdown were further abolished by TBL1XR1 overexpression. In addition, USP9X promoted the NF-κB signaling pathway by the deubiquitination of TBL1XR1. Conclusion: USP9X promoted the apoptosis, inflammation, and oxidative stress of LPS-stimulated WI-38 cells through the deubiquitination of TBL1XR1.</p>","PeriodicalId":21667,"journal":{"name":"SHOCK","volume":"63 2","pages":"210-216"},"PeriodicalIF":2.9000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"SHOCK","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/SHK.0000000000002442","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract: Background: Ubiquitination and deubiquitination are involved in the progression of human diseases, including acute pneumonia. In this study, we aimed to explore the functions of ubiquitin-specific peptidase 9X-linked (USP9X) in lipopolysaccharide (LPS)-treated WI-38 cells. Methods: WI-38 cells were treated with LPS to induce the cellular damage and inflammation. 3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) assay, and 5-ethynyl-2'-deoxyuridine (EdU) assay were performed to examine the proliferation of LPS-treated WI-38 cells. Flow cytometry analysis was conducted to detect LPS-treated WI-38 cell apoptosis. ELISA kits were utilized to determine the concentrations of inflammatory factors (IL-1β and TNF-α). Superoxide dismutase activity and reactive oxygen species level were examined with related kits. Ubibrowser (http://ubibrowser.bio-it.cn/ubibrowser/), ubiquitination assay, and co-immunoprecipitation assay demonstrated the interaction between USP9X and transducin β-like 1X related protein 1 (TBL1XR1). qRT-PCR assay and western blot assay were manipulated to determine the expression of USP9X and TBL1XR1. TBL1XR1 and USP9X knockdown experiments were conducted to explore their functions on LPS-induced WI-38 cell injury and inflammation. Results: TBL1XR1 expression was upregulated in LPS-treated WI-38 cells. TBL1XR1 knockdown promoted cell proliferation and repressed apoptosis, inflammation, and oxidative stress in LPS-treated WI-38 cells. Moreover, USP9X deubiquitinated TBL1XR1 to regulate TBL1XR1 expression. USP9X knockdown restored the effects of LPS on WI-38 cell proliferation, apoptosis, inflammation, and oxidative stress, but these effects of USP9X knockdown were further abolished by TBL1XR1 overexpression. In addition, USP9X promoted the NF-κB signaling pathway by the deubiquitination of TBL1XR1. Conclusion: USP9X promoted the apoptosis, inflammation, and oxidative stress of LPS-stimulated WI-38 cells through the deubiquitination of TBL1XR1.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Usp9x通过调控tbl1xr1去泛素化促进脂多糖诱导的成纤维细胞凋亡、炎症和氧化应激。
摘要:背景:泛素化和去泛素化参与人类疾病的进展,包括急性肺炎。在这项研究中,我们旨在探讨泛素特异性肽酶9X-linked (USP9X)在脂多糖(LPS)处理的WI-38细胞中的功能。方法:LPS处理WI-38细胞,诱导细胞损伤和炎症反应。采用3-(4,5 -二甲基-2-噻唑基)- 2,5 -二苯基-2- h -溴化四唑(MTT)法和5-乙基-2'-脱氧尿苷(EdU)法检测lps处理的WI-38细胞的增殖情况。流式细胞术检测lps处理后WI-38细胞凋亡情况。采用ELISA试剂盒检测炎症因子(IL-1β和TNF-α)浓度。用相关试剂盒检测超氧化物歧化酶活性和活性氧水平。泛素浏览器(http://ubibrowser.bio-it.cn/ubibrowser/)、泛素化实验和共免疫沉淀实验证实了USP9X与转导蛋白β样1X相关蛋白1 (TBL1XR1)之间的相互作用。采用qRT-PCR法和western blot法检测USP9X和TBL1XR1的表达。通过TBL1XR1和USP9X敲低实验,探讨其对lps诱导的WI-38细胞损伤和炎症的作用。结果:TBL1XR1在lps处理的WI-38细胞中表达上调。在lps处理的WI-38细胞中,TBL1XR1敲低可促进细胞增殖,抑制凋亡、炎症和氧化应激。此外,USP9X使TBL1XR1去泛素化,从而调节TBL1XR1的表达。USP9X敲低恢复了LPS对WI-38细胞增殖、凋亡、炎症和氧化应激的影响,但这些作用被TBL1XR1过表达进一步消除。此外,USP9X通过TBL1XR1的去泛素化促进NF-κB信号通路。结论:USP9X通过TBL1XR1的去泛素化作用促进lps刺激的WI-38细胞的凋亡、炎症和氧化应激。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
SHOCK
SHOCK 医学-外科
CiteScore
6.20
自引率
3.20%
发文量
199
审稿时长
1 months
期刊介绍: SHOCK®: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches includes studies of novel therapeutic approaches, such as immunomodulation, gene therapy, nutrition, and others. The mission of the Journal is to foster and promote multidisciplinary studies, both experimental and clinical in nature, that critically examine the etiology, mechanisms and novel therapeutics of shock-related pathophysiological conditions. Its purpose is to excel as a vehicle for timely publication in the areas of basic and clinical studies of shock, trauma, sepsis, inflammation, ischemia, and related pathobiological states, with particular emphasis on the biologic mechanisms that determine the response to such injury. Making such information available will ultimately facilitate improved care of the traumatized or septic individual.
期刊最新文献
Cardiovascular Risk Score (SCORE2) Predicts the Incidence and Severity of Cardiac Damage after Polytrauma - How to Identify At-risk Patients? Bridging bench to bedside: mechanistic elucidation and clinical translation of vasopressin and its analogues for hemorrhagic shock resuscitation. A Meta-Analytic Perspective on Echocardiographic Signs of Long-Term Cardiac Dysfunction After Burns, Sepsis, and Trauma. Genetic Evidence Reveals a Causal Association Between Plasma Phosphatidylcholine Levels and Sepsis Associated Mortality, With Immune Cells Mediating This Association. Nicotinamide Riboside Alleviates Heat Stress-induced Intestinal Barrier Dysfunction in Mice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1